Charles River expands early discovery services

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/JK1991)
(Image: Getty/JK1991)
Charles River has upped to its early discovery capabilities with the addition of high-throughput technologies and expanded pharmacokinetic services.

According to Charles River, it is the first contract research organization (CRO) to provide clients access to Apricot Designs' Dual Arm (ADDA) system in North America and Europe.

Designed for drug discovery, the system is a high-speed autosampler for liquid chromatography/mass spectrometry (LC/MS).

“Apricot Designs’ dual arm autosampler was designed with early discovery scientists in mind,” ​said Felix H. Yiu, founder and CEO, Apricot Designs, Inc. in a press release. “It enables seamless integration with LC/MS systems, accelerating the laboratory research process and yielding the best results.”

Charles River has also geographically expanded its pharmacokinetic (PK) capabilities in San Francisco and 's-Hertogenbosch, The Netherlands.

“The early discovery industry is seeing a marked shift towards a better understanding of the underlying biology of candidate compounds. Both HT-ADME and PK technologies are critical to that understanding, and to developing more successful candidates in early discovery,”​ explained Ian Waddell, PhD, executive director, biology, Charles River.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers

Follow us


View more